179 research outputs found

    Postural instability in an immersive Virtual Reality adapts with repetition and includes directional and gender specific effects

    Get PDF
    The ability to handle sensory conflicts and use the most appropriate sensory information is vital for successful recovery of human postural control after injury. The objective was to determine if virtual reality (VR) could provide a vehicle for sensory training, and determine the temporal and spatial nature of such adaptive changes. Twenty healthy subjects participated in the study (10 females). The subjects watched a 90-second VR simulation of railroad (rollercoaster) motion in mountainous terrain during five repeated simulations, while standing on a force platform that recorded their stability. The immediate response to watching the VR movie was an increased level of postural instability. Repeatedly watching the same VR movie significantly reduced both the anteroposterior (62%, p < 0.001) and lateral (47%, p = 0.001) energy used. However, females adapted more slowly to the VR stimuli as reflected by higher use of total (p = 0.007), low frequency (p = 0.027) and high frequency (p = 0.026) energy. Healthy subjects can significantly adapt to a multidirectional, provocative, visual environment after 4–5 repeated sessions of VR. Consequently, VR technology might be an effective tool for rehabilitation involving visual desensitisation. However, some females may require more training sessions to achieve effects with VR

    Search for a Light Sterile Neutrino at Daya Bay

    Get PDF
    published_or_final_versio

    Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects

    Get PDF
    Over the last decade, pioneering liver-directed gene therapy trials for haemophilia B have achieved sustained clinical improvement after a single systemic injection of adeno-associated virus (AAV) derived vectors encoding the human factor IX cDNA. These trials demonstrate the potential of AAV technology to provide long-lasting clinical benefit in the treatment of monogenic liver disorders. Indeed, with more than ten ongoing or planned clinical trials for haemophilia A and B and dozens of trials planned for other inherited genetic/metabolic liver diseases, clinical translation is expanding rapidly. Gene therapy is likely to become an option for routine care of a subset of severe inherited genetic/metabolic liver diseases in the relatively near term. In this review, we aim to summarise the milestones in the development of gene therapy, present the different vector tools and their clinical applications for liver-directed gene therapy. AAV-derived vectors are emerging as the leading candidates for clinical translation of gene delivery to the liver. Therefore, we focus on clinical applications of AAV vectors in providing the most recent update on clinical outcomes of completed and ongoing gene therapy trials and comment on the current challenges that the field is facing for large-scale clinical translation. There is clearly an urgent need for more efficient therapies in many severe monogenic liver disorders, which will require careful risk-benefit analysis for each indication, especially in paediatrics

    The muon system of the Daya Bay Reactor antineutrino experiment

    Get PDF
    postprin

    Improved measurement of the reactor antineutrino flux and spectrum at Daya Bay

    Get PDF
    published_or_final_versio

    Measurement of electron antineutrino oscillation based on 1230 days of operation of the Daya Bay experiment

    Get PDF
    published_or_final_versio

    Improved Search for a Light Sterile Neutrino with the Full Configuration of the Daya Bay Experiment

    Get PDF
    published_or_final_versio

    Evolution of the Reactor Antineutrino Flux and Spectrum at Daya Bay

    Get PDF
    published_or_final_versio

    Independent measure of the neutrino mixing angle θ13 via neutron capture on hydrogen at Daya Bay

    Get PDF
    published_or_final_versio
    corecore